Download PDF
Dtsch Med Wochenschr 2013; 138(36): 1780-1784
DOI: 10.1055/s-0033-1343347
Aktuelle Diagnostik & Therapie | Review article
Viszeralmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Resektion oder lokal-ablative Therapie bei hepatozellulärem Karzinom: welche Methode für welche Patienten?

Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?
H. Lang
1   Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsmedizin Mainz
,
J. Ricke
2   Klinik für Radiologie und Nuklearmedizin, Universitätsklinikum Magdeburg
,
J. Schlaak
3   Lebertumorcentrum (LTC) am Westdeutschen Tumorzentrum, Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Essen
› Author Affiliations
Further Information

Publication History

25 April 2013

08 August 2013

Publication Date:
13 August 2013 (online)

Also available at
    Permissions and Reprints

See also:

Viszeralmedizin: Ko-operieren statt konkurrieren – Gemeinsamkeit macht stark!Dtsch Med Wochenschr 2013; 138(36): 1757-1758
DOI: 10.1055/s-0033-1349482

Schlüsselwörter

hepatozelluläres Karzinom (HCC) - stadienadaptierte Therapie - Leberteilresektion - transarterielle Chemoembolisation (TACE) - Lebertransplantation

Keywords

hepatocellular carcinoma (HCC) - treatment according to stage - liver resection - transarterial chemo- embolisation (TACE) - liver transplantation
 

  • Literatur

  • 1 EASL-EORTC. Clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 2012; 48: 599-641
    CrossrefPubMedGoogle Scholar
  • 2 Belghiti J, Cortes A, Abdalla EK et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238 (06) 885-892
    CrossrefPubMedGoogle Scholar
  • 3 Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395
    CrossrefPubMedGoogle Scholar
  • 4 Burrel M, Reig M, Forner A et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol 2012; 56: 1330-1335
    CrossrefPubMedGoogle Scholar
  • 5 Burrel S, it-Arkoub Z, Agut H et al. Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor. Antiviral Res 2012; 93: 199-203
    CrossrefPubMedGoogle Scholar
  • 6 Chen JG, Zhu J, Parkin DM et al. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 2006; 119: 1447-1454
    CrossrefPubMedGoogle Scholar
  • 7 Decaens T, Roudot-Thoraval F, Bresson-Hadni S et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005; 11: 767-775
    CrossrefPubMedGoogle Scholar
  • 8 Fan ST, Poon RT, Yeung C et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg 2011; 98: 1292-1300
    CrossrefPubMedGoogle Scholar
  • 9 Hilgard P, Hamami M, Fouly AE et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010; 52: 1741-1749
    CrossrefPubMedGoogle Scholar
  • 10 Hu HT, Kim JH, Lee LS et al. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol 2011; 22: 917-923
    CrossrefPubMedGoogle Scholar
  • 11 Hwang S, Lee SG, Joh JW et al. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005; 11: 1265-1272
    CrossrefPubMedGoogle Scholar
  • 12 Ibarra RA, Rojas D, Snyder L et al. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol 2012; 51: 575-583
    CrossrefPubMedGoogle Scholar
  • 13 Lammer J, Malagari K, Vogl T et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33: 41-52
    CrossrefPubMedGoogle Scholar
  • 14 Lang H, Sotiropoulos GC, Domland M et al. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg 2005; 92: 198-202
    CrossrefPubMedGoogle Scholar
  • 15 Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442
    CrossrefPubMedGoogle Scholar
  • 16 Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. Lancet 2002; 359: 1734-1739
    CrossrefPubMedGoogle Scholar
  • 17 Llovet JM, Ricci S, Mazzaferro V et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390
    CrossrefPubMedGoogle Scholar
  • 18 Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171
    CrossrefPubMedGoogle Scholar
  • 19 Malago M, Sotiropoulos GC, Nadalin S et al. Living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2006; 12: 934-940
    CrossrefPubMedGoogle Scholar
  • 20 Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
    CrossrefPubMedGoogle Scholar
  • 21 Merchant N, David CS, Cunningham SC. Early hepatocellular carcinoma: transplantation versus resection: the case for liver resection. Int J Hepatol 2011; 2011: 142085
    PubMedGoogle Scholar
  • 22 Mohnike K, Wieners G, Schwartz F et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 2010; 78: 172-179
    CrossrefPubMedGoogle Scholar
  • 23 Otto G, Herber S, Heise M et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006; 12: 1260-1267
    CrossrefPubMedGoogle Scholar
  • 24 Salem R, Lewandowski RJ, Kulik L et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011; 140: 497-507
    CrossrefPubMedGoogle Scholar
  • 25 Salem R, Lewandowski RJ, Mulcahy MF et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138: 52-64
    CrossrefPubMedGoogle Scholar
  • 26 Sangro B, Carpanese L, Cianni R et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages. Hepatology 2011; 54: 868-878
    CrossrefPubMedGoogle Scholar
  • 27 Schnitzbauer A, Lang SA, Goessmann H et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012; 255: 404-414
    CrossrefPubMedGoogle Scholar
  • 28 Yamasaki T, Hamabe S, Saeki I et al. A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial. J Gastroenterol 2011; 46: 359-366
    CrossrefPubMedGoogle Scholar
  • 29 Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403
    CrossrefPubMedGoogle Scholar
  • 30 Cherqui D, Laurent A, Mocellin N et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009; 250: 738-746
    CrossrefPubMedGoogle Scholar
  • 31 Cescon M, Cucchetti A, Grazi GL et al. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg 2009; 144: 57-63
    CrossrefPubMedGoogle Scholar
  • 32 AWMF. S3-Leitlinie Hepatozelluläres Karzinom. http://www.awmf.org/leitlinien/detail/ll/032-053OL.html
    Google Scholar